Am J Perinatol 2019; 36(04): 366-376
DOI: 10.1055/s-0038-1668555
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Treatment of Iron Deficiency Anemia in Pregnancy with Intravenous versus Oral Iron: Systematic Review and Meta-Analysis

Shravya Govindappagari
1   Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California
,
Richard M. Burwick
1   Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California
› Institutsangaben
Weitere Informationen

Publikationsverlauf

18. März 2018

11. Juli 2018

Publikationsdatum:
19. August 2018 (online)

Abstract

Objective To perform a systematic review and meta-analysis of randomized controlled trials (RCTs) to assess the benefits of intravenous (IV) iron in pregnancy.

Study Design Systematic review was registered with PROSPERO and performed using PRISMA guidelines. PubMed, MEDLINE, Web of Science, ClinicalTrials.gov, Cochrane Library, and Google Scholar were searched. Eleven RCTs, comparing IV to oral iron for treatment of iron-deficiency anemia in pregnancy, were included. Meta-analyses were performed with Stata software (College Station, TX), utilizing random effects model and method of DerSimonian and Laird. Outcomes were assessed by pooled odds ratios (OR) or pooled weighted mean difference (WMD). Sensitivity analyses were performed for heterogeneity.

Results We found that pregnant women receiving IV iron, compared with oral iron, had the following benefits: (1) Achieved target hemoglobin more often, pooled OR 2.66 (95% confidence interval [CI]: 1.71–4.15), p < 0.001; (2) Increased hemoglobin level after 4 weeks, pooled WMD 0.84 g/dL (95% CI: 0.59–1.09), p < 0.001; (3) Decreased adverse reactions, pooled OR 0.35 (95% CI: 0.18–0.67), p = 0.001. Results were unchanged following sensitivity analyses.

Conclusion In this meta-analysis, IV iron is superior to oral iron for treatment of iron-deficiency anemia in pregnancy. Women receiving IV iron more often achieve desired hemoglobin targets, faster and with fewer side effects.

Note

These findings were presented as an oral presentation at the American College of Obstetricians and Gynecologists 2018 Annual Clinical and Scientific Meeting, April 27–30, Austin, TX.


 
  • References

  • 1 WHO. The global prevalence of anaemia in 2011. Geneva: World Health Organization; 2015
  • 2 Le CH. The Prevalence of anemia and moderate-severe anemia in the US population (NHANES 2003-2012). PLoS One 2016; 11 (11) e0166635
  • 3 Mei Z, Cogswell ME, Looker AC. , et al. Assessment of iron status in US pregnant women from the National Health and Nutrition Examination Survey (NHANES), 1999-2006. Am J Clin Nutr 2011; 93 (06) 1312-1320
  • 4 Rahman MM, Abe SK, Rahman MS. , et al. Maternal anemia and risk of adverse birth and health outcomes in low- and middle-income countries: systematic review and meta-analysis. Am J Clin Nutr 2016; 103 (02) 495-504
  • 5 Dilla AJ, Waters JH, Yazer MH. Clinical validation of risk stratification criteria for peripartum hemorrhage. Obstet Gynecol 2013; 122 (01) 120-126
  • 6 Committee on Practice Bulletins-Obstetrics. Practice bulletin no. 183: postpartum hemorrhage. Obstet Gynecol 2017; 130 (04) e168-e186
  • 7 Earl R, Woteki CE. , eds. Iron Deficiency Anemia: Recommended Guidelines for The Prevention, Detection, and Management among U.S. Children and Women of Childbearing Age. Washington, DC: National Academy Press; 1993
  • 8 Cancelo-Hidalgo MJ, Castelo-Branco C, Palacios S. , et al. Tolerability of different oral iron supplements: a systematic review. Curr Med Res Opin 2013; 29 (04) 291-303
  • 9 Moretti D, Goede JS, Zeder C. , et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood 2015; 126 (17) 1981-1989
  • 10 Camaschella C. Iron-deficiency anemia. N Engl J Med 2015; 372 (19) 1832-1843
  • 11 Avni T, Bieber A, Grossman A, Green H, Leibovici L, Gafter-Gvili A. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc 2015; 90 (01) 12-23
  • 12 Reveiz L, Gyte GM, Cuervo LG. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev 2007; 18 (02) CD003094
  • 13 Reveiz L, Gyte GM, Cuervo LG, Casasbuenas A. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev 2011; 5 (10) CD003094
  • 14 Stroup DF, Berlin JA, Morton SC. , et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283 (15) 2008-2012
  • 15 Abhilashini GD, Sagili H, Reddi R. Intravenous iron sucrose and oral iron for the treatment of iron deficiency anaemia in pregnancy. J Clin Diagn Res 2014; 8 (05) OC04-OC07
  • 16 Aggarwal R, Mishra VV, Panchal NA, Patel NH, Deshchougule VV, Jasani AF. Evaluation of iron sucrose and oral iron in management of iron deficiency anemia in pregnancy. Natl J Community Med 2012; 3 (01) 55-60
  • 17 Al RA, Unlubilgin E, Kandemir O, Yalvac S, Cakir L, Haberal A. Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial. Obstet Gynecol 2005; 106 (06) 1335-1340
  • 18 Bayoumeu F, Subiran-Buisset C, Baka NE, Legagneur H, Monnier-Barbarino P, Laxenaire MC. Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. Am J Obstet Gynecol 2002; 186 (03) 518-522
  • 19 Bhavi SB, Jaju PB. Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial. BMC Pregnancy Childbirth 2017; 17 (01) 137
  • 20 Breymann C, Milman N, Mezzacasa A, Bernard R, Dudenhausen J. ; FER-ASAP investigators. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP). J Perinat Med 2017; 45 (04) 443-453
  • 21 Darwish AM, Khalifa EE, Rashad E, Farghally E. Total dose iron dextran infusion versus oral iron for treating iron deficiency anemia in pregnant women: a randomized controlled trial. J Matern Fetal Neonatal Med 2017; DOI: 10.1080/14767058.2017.1379988.
  • 22 Gupta A, Manaktala U, Rathore AM. A randomised controlled trial to compare intravenous iron sucrose and oral iron in treatment of iron deficiency anemia in pregnancy. Indian J Hematol Blood Transfus 2014; 30 (02) 120-125
  • 23 Kochhar PK, Kaundal A, Ghosh P. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial. J Obstet Gynaecol Res 2013; 39 (02) 504-510
  • 24 Neeru S, Nair NS, Rai L. Iron sucrose versus oral iron therapy in pregnancy anemia. Indian J Community Med 2012; 37 (04) 214-218
  • 25 Shafi D, Purandare SV, Sathe AV. Iron deficiency anemia in pregnancy: intravenous versus oral route. J Obstet Gynaecol India 2012; 62 (03) 317-321
  • 26 Higgins JPT, Green S. , eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration; 2011. . Available at: http://handbook.cochrane.org . Accessed August 8, 2018
  • 27 Haider BA, Olofin I, Wang M, Spiegelman D, Ezzati M, Fawzi WW. ; Nutrition Impact Model Study Group (anaemia). Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ 2013; 346: f3443
  • 28 Perez EM, Hendricks MK, Beard JL. , et al. Mother-infant interactions and infant development are altered by maternal iron deficiency anemia. J Nutr 2005; 135 (04) 850-855
  • 29 Love AL, Billett HH. Obesity, bariatric surgery, and iron deficiency: true, true, true and related. Am J Hematol 2008; 83 (05) 403-409
  • 30 Krafft A, Breymann C, Huch R, Huch A. Intravenous iron sucrose in two pregnant women with inflammatory bowel disease and severe iron deficiency anemia. Acta Obstet Gynecol Scand 2000; 79 (08) 720-722
  • 31 Hershko C, Hoffbrand AV, Keret D. , et al. Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia. Haematologica 2005; 90 (05) 585-595
  • 32 Nashaat EH, Mansour GM. Helicobacter pylori and anemia with pregnancy. Arch Gynecol Obstet 2014; 289 (06) 1197-1202
  • 33 Shinar S, Skornick-Rapaport A, Maslovitz S. Iron supplementation in singleton pregnancy: Is there a benefit to doubling the dose of elemental iron in iron-deficient pregnant women? a randomized controlled trial. J Perinatol 2017; 37 (07) 782-786
  • 34 Ganz T, Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol 2006; 290 (02) G199-G203
  • 35 Lyndon A, Lagrew D, Shields L, Main E, Cape V. Improving Health Care Response to Obstetric Hemorrhage. (California Maternal Quality Care Collaborative Toolkit to Transform Maternity Care) Developed under contract #11–10006 with the California Department of Public Health. Maternal, Child and Adolescent Health Division: Published by the California Maternal Quality Care Collaborative; 2015
  • 36 Muñoz M, Peña-Rosas JP, Robinson S. , et al. Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period: NATA consensus statement. Transfus Med 2018; 28 (01) 22-39
  • 37 WHO. Global nutrition targets 2025: Anaemia policy brief (WHO/NMH/NHD/14.4). Geneva: World Health Organization; 2014. . Available at: http://www.who.int/nutrition/topics/globaltargets_anaemia_policybrief.pdf . Accessed August 8, 2018
  • 38 Bailie GR. Comparison of rates of reported adverse events associated with i.v. iron products in the United States. Am J Health Syst Pharm 2012; 69 (04) 310-320
  • 39 Auerbach M, Pappadakis JA, Bahrain H, Auerbach SA, Ballard H, Dahl NV. Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia. Am J Hematol 2011; 86 (10) 860-862
  • 40 Auerbach M, James SE, Nicoletti M. , et al. Results of the first american prospective study of intravenous iron in oral iron-intolerant iron-deficient gravidas. Am J Med 2017; 130 (12) 1402-1407
  • 41 Christoph P, Schuller C, Studer H, Irion O, De Tejada BM, Surbek D. Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose. J Perinat Med 2012; 40 (05) 469-474
  • 42 Funk F, Ryle P, Canclini C, Neiser S, Geisser P. The new generation of intravenous iron: chemistry, pharmacology, and toxicology of ferric carboxymaltose. Arzneimittelforschung 2010; 60 (6a): 345-353
  • 43 Wong L, Smith S, Gilstrop M. , et al. Safety and efficacy of rapid (1,000 mg in 1 hr) intravenous iron dextran for treatment of maternal iron deficient anemia of pregnancy. Am J Hematol 2016; 91 (06) 590-593
  • 44 Crichton RR, Danielson BG, Geisser P. Iron therapy: with special emphasis on intravenous administration. Bremen, Germany: Uni-Med Verlag; 2006
  • 45 Lane DJ, Chikhani S, Richardson V, Richardson DR. Transferrin iron uptake is stimulated by ascorbate via an intracellular reductive mechanism. Biochim Biophys Acta 2013; 1833 (06) 1527-1541
  • 46 Lane DJ, Jansson PJ, Richardson DR. Bonnie and clyde: vitamin c and iron are partners in crime in iron deficiency anaemia and its potential role in the elderly. Aging (Albany NY) 2016; 8 (05) 1150-1152
  • 47 Malik R, Guleria K, Kaur I, Sikka M, Radhakrishnan G. Effect of Helicobacter pylori eradication therapy in iron deficiency anaemia of pregnancy - a pilot study. Indian J Med Res 2011; 134: 224-231
  • 48 Iriye BK, Gregory KD, Saade GR, Grobman WA, Brown HL. Quality measures in high-risk pregnancies: Executive Summary of a Cooperative Workshop of the Society for Maternal-Fetal Medicine, National Institute of Child Health and Human Development, and the American College of Obstetricians and Gynecologists. Am J Obstet Gynecol 2017; 217 (04) B2-B25
  • 49 Solheim KN, Esakoff TF, Little SE, Cheng YW, Sparks TN, Caughey AB. The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreta, and maternal mortality. J Matern Fetal Neonatal Med 2011; 24 (11) 1341-1346
  • 50 Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol 2007; 110 (2 Pt 1): 267-278
  • 51 Breymann C, Gliga F, Bejenariu C, Strizhova N. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. Int J Gynaecol Obstet 2008; 101 (01) 67-73